Evidence map›Paper›PMID 20177070›Full record

ArticleThe Journal of biological chemistry2010

Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity.

Christopher R Weber, David R Raleigh, Liping Su, Le Shen, Erika A Sullivan, Yingmin Wang, Jerrold R Turner

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 179 papers.

0numbers the graph read from it
0cells of the map it votes in
179citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

179 citing papers in PubMed, 280 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Tight Junction Defects in Aganglionic and Ganglionic Colon in Children With Hirschsprung Disease.Laboratory investigation; a journal of technical methods and pathology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. The Pathogenesis of Inflammatory Bowel Diseases.The Surgical clinics of North America · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Efficacy ofNutrients · 2024
    Article

119 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christopher R WeberDepartment of Pathology, The University of Chicago, Chicago, Illinois 60637, USA.
David R Raleigh
Liping Su
Le Shen
Erika A Sullivan
Yingmin Wang
Jerrold R Turner
University of Chicago · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
ZO-1-MEDIATED PROTEIN INTERACTIONS: REGULATORS AND INTEGRATORS OF DIVERSE EPITHELIAL FUNCTIONS IN HEALTH AND DISEASER01DK061931 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2001 to 2026
$15.0M
Therapeutic targeting of protein interactions to reverse MLCK1-mediated intestinal barrier loss and ameliorate disease.R01DK068271 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2005 to 2026
$11.3M
CARDIOVASCULAR PATHOPHYSIOLOGY &BIOCHEMISTRY TRAININGT32HL007237 · NHLBI · UNIVERSITY OF CHICAGO · PI GETZ, GODFREY SHALOM · 1985 to 2011
$5.0M
Transcriptional Regulation of NHE-3 Isoform in Human IntestineP01DK067887 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HECHT, GAIL A · 2006 to 2011
$4.9M
HTS ASSAYS FOR INHIBITORS OF PROTEIN INTERACTIONS INCLUDING MLCK1-FKBP8R56DK094954 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MILLER, LAWRENCE, TURNER, JERROLD R. · 2012 to 2012
$157k
Mechanisms of epithelial barrier dysfunction mediated by inflammatory cytokinesF32DK082134 · NIDDK · UNIVERSITY OF CHICAGO · PI WEBER, CHRISTOPHER · 2008 to 2009
$108k
NCI NIH HHS P30 CA014599NCI NIH HHS P30CA14599NHLBI NIH HHS T32 HL007237NIDDK NIH HHS F32 DK082134NIDDK NIH HHS F32DK082134NIDDK NIH HHS P01 DK067887NIDDK NIH HHS P01DK67887NIDDK NIH HHS R01 DK061931NIDDK NIH HHS R01 DK068271NIDDK NIH HHS R01DK61931NIDDK NIH HHS R01DK68271NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

Intestinal barrier function is reduced in inflammatory bowel disease (IBD). Tumor necrosis factor (TNF) and interleukin (IL)-13, which are up-regulated in IBD, induce barrier defects that are associated with myosin light chain kinase (MLCK) activation and increased claudin-2 expression, respectively, in cultured intestinal epithelial monolayers. Here we report that these independent signaling pathways have distinct effects on tight junction barrier properties and interact in vivo. MLCK activation alters size selectivity to enhance paracellular flux of uncharged macromolecules without affecting charge selectivity and can be rapidly reversed by MLCK inhibition. In contrast, IL-13-dependent claudin-2 expression increases paracellular cation flux in vitro and in vivo without altering tight junction size selectivity but is unaffected by MLCK inhibition in vitro. In vivo, MLCK activation increases paracellular flux of uncharged macromolecules and also triggers IL-13 expression, claudin-2 synthesis, and increased paracellular cation flux. We conclude that reversible, MLCK-dependent permeability increases cause mucosal immune activation that, in turn, feeds back on the tight junction to establish long-lasting barrier defects. Interactions between these otherwise distinct tight junction regulatory pathways may contribute to IBD pathogenesis.

Indexed as

AnimalsBase SequenceCaco-2 CellsCell LineClaudinsEnzyme ActivationHumansInflammatory Bowel DiseasesInterleukin-13Intestinal MucosaIon TransportMembrane ProteinsMiceMice, TransgenicMyosin-Light-Chain KinaseRecombinant ProteinsClaudinsCLDN2 protein, humanCldn2 protein, mouseInterleukin-13Membrane ProteinsMyosin-Light-Chain KinaseRecombinant ProteinsRNA, MessengerRNA, Small InterferingTumor Necrosis Factor-alpha

Identifiers

PMID20177070
PMCPMC2852941
OpenAlexW2013657751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.